Autologous adipose-derived stromal vascular fraction (Swiss Medica XXI Century)

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NameAutologous adipose-derived stromal vascular fraction (Swiss Medica XXI Century)

Drug Alias Name自体脂肪源基质血管组分细胞-Swiss Medica XXI CenturyAdministration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cellsautologous SVFconcentrate stromal vascular fraction of cells (SVF)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, Knee

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySerbiaRussian Federation

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSwiss Medica Xxi Century Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSwiss Medica Xxi Century Sa

Active IndicationsN/A

Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A